References
- Lipinski CA. (2000). Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods, 44:235–249.
- Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 46:3–26.
- Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413–420.
- Takagi T, Ramachandran C, Bermejo M, Yamashita S, Yu LX, Amidon GL. (2006). A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol Pharm, 3:631–643.
- He X, Kadomura S, Takekuma Y, Sugawara M, Miyazaki K. (2004). A new system for the prediction of drug absorption using a pH-controlled Caco-2 model: evaluation of pH-dependent soluble drug absorption and pH-related changes in absorption. J Pharm Sci, 93:71–77.
- Neuvonen PJ, Kivistö KT. (1991). The effects of magnesium hydroxide on the absorption and efficacy of two glibenclamide preparations. Br J Clin Pharmacol, 32:215–220.
- Alves NM, Mano JF. Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications. Int J Biol Macromol 2008;43:401–414.
- Paños I, Acosta N, Heras A. (2008). New drug delivery systems based on chitosan. Curr Drug Discov Technol, 5:333–341.
- Adhikary A, Vavia PR. (2008). Bioadhesive ranitidine hydrochloride for gastroretention with controlled microenvironmental pH. Drug Dev Ind Pharm, 34:860–869.
- Accili D, Menghi G, Bonacucina G, Martino PD, Palmieri GF. (2004). Mucoadhesion dependence of pharmaceutical polymers on mucosa characteristics. Eur J Pharm Sci, 22:225–234.
- Bromberg L, Temchenko M, Alakhov V, Hatton TA. (2004). Bioadhesive properties and rheology of polyether-modified poly(acrylic acid) hydrogels. Int J Pharm, 282:45–60.
- Bernkop-Schnürch A. (2000). Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int J Pharm, 194:1–13.
- Tengamnuay P, Sahamethapat A, Sailasuta A, Mitra AK. (2000). Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. Int J Pharm, 197:53–67.
- Senel S, Kremer MJ, Kas S, Wertz PW, Hincal AA, Squier CA. (2000). Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials, 21:2067–2071.
- Perioli L, Ambrogi V, Venezia L, Pagano C, Ricci M, Rossi C. (2008). Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels. Colloids Surf B Biointerfaces, 66:141–145.
- Sugaya Y, Yoshiba T, Kajima T, Ishihama Y. (2002). [Development of solubility screening methods in drug discovery]. Yakugaku Zasshi, 122:237–246.
- Kawano Y, Ito A, Sasatsu M, Machida Y, Onishi H. (2010). [Preparation and evaluation of taste masked orally disintegrating tablets with granules made by the wet granulation method]. Yakugaku Zasshi, 130:1737–1742.
- Ranga KV, Rao Buri, P. A novel in situ method to test polymers and coated microparticles for bioadhesion. Int J Pharm 1989;52:265–270.
- Bollman JL, Cain JC, Grindlay JH. (1948). Techniques for the collection of lymph from the liver, small intestine, or thoracic duct of the rat. J Lab Clin Med, 33:1349–1352.
- Prentis RA, Lis Y, Walker SR. (1988). Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964–1985). Br J Clin Pharmacol, 25:387–396.
- Shore PA, Brodie BB, Hogben CA. (1957). The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther, 119:361–369.
- Koljonen M, Hakala KS, Ahtola-Sätilä T, Laitinen L, Kostiainen R, Kotiaho T et al. (2006). Evaluation of cocktail approach to standardise Caco-2 permeability experiments. Eur J Pharm Biopharm, 64:379–387.
- Bigucci F, Luppi B, Cerchiara T, Sorrenti M, Bettinetti G, Rodriguez L et al. (2008). Chitosan/pectin polyelectrolyte complexes: selection of suitable preparative conditions for colon-specific delivery of vancomycin. Eur J Pharm Sci, 35:435–441.
- Dodane V, Amin Khan M, Merwin JR. (1999). Effect of chitosan on epithelial permeability and structure. Int J Pharm, 182:21–32.